Author Topic: Whether gadolinium should always be used to assess disease activity in MS  (Read 37 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest

The Multiple Sclerosis Journal sometimes gives the pro and con arguments on a controversial topic, followed by a commentary summing up the two discussions. On June 1 the topic was whether gadolinium should always be used to assess disease activity in MS. The link below gives the first part of the argument against gadolinium:



https://journals.sagepub.com/doi/abs/10.1177/1352458520914819
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
32 Views
Last post October 22, 2020, 08:52:36 pm
by agate
0 Replies
25 Views
Last post January 15, 2023, 04:14:45 pm
by agate
2 Replies
30 Views
Last post June 30, 2023, 03:12:01 pm
by agate
0 Replies
14 Views
Last post October 16, 2023, 09:21:58 pm
by agate
0 Replies
12 Views
Last post December 22, 2023, 02:22:50 pm
by agate